Related Experiment Video
Updated: Jun 19, 2026
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
The Promise of Molecular Imaging: Focus on Central Nervous System Infections
Swati Shah1, Mitchell L Turner1, Xueyi Chen2
1Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Abstract:
Central nervous system (CNS) infections can lead to high mortality and severe morbidity. Diagnosis, monitoring, and assessing response to therapy of CNS infections is particularly challenging with traditional tools, such as microbiology, due to the dangers associated with invasive CNS procedures (ie, biopsy or surgical resection) to obtain tissues. Molecular imaging techniques like positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging have long been used to complement anatomic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI), for in vivo evaluation of disease pathophysiology, progression, and treatment response. In this review, we detail the use of molecular imaging to delineate host-pathogen interactions, elucidate antimicrobial pharmacokinetics, and monitor treatment response. We also discuss the utility of pathogen-specific radiotracers to accurately diagnose CNS infections and strategies to develop radiotracers that would cross the blood-brain barrier.
Insights
Molecular imaging offers a safer, more effective way to diagnose and monitor central nervous system (CNS) infections. This approach aids in understanding host-pathogen interactions and treatment efficacy, improving patient outcomes.
Area of Science:
- Neurology
- Infectious Diseases
- Medical Imaging
Background:
- Central nervous system (CNS) infections present significant diagnostic and monitoring challenges due to the risks of invasive procedures.
- Traditional methods like microbiology are limited by the need for tissue samples, posing risks to patients.
- Anatomic imaging (CT, MRI) lacks the functional insights provided by molecular imaging.
Approach:
- This review explores the application of molecular imaging techniques, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT).
- It details how these methods can delineate host-pathogen interactions and antimicrobial pharmacokinetics.
- The review also discusses the development of pathogen-specific radiotracers capable of crossing the blood-brain barrier.
Key Points:
- Molecular imaging complements anatomic imaging for in vivo evaluation of CNS infection pathophysiology and progression.
- It enables non-invasive assessment of treatment response, crucial for managing CNS infections.
- Development of targeted radiotracers is key for accurate, early diagnosis and effective monitoring.
Conclusions:
- Molecular imaging provides a powerful, less invasive alternative for diagnosing and managing CNS infections.
- It offers critical insights into disease mechanisms and treatment effectiveness.
- Future advancements in radiotracer development promise enhanced diagnostic capabilities for CNS infections.
